Abstract
In contrast to rheumatoid arthritis (RA), the triggering antigens are known in reactive arthritis (ReA) and Lyme arthritis. Thus, in these arthritides the antigen-specific T-cell response can be investigated in much detail and lessons possibly learned for other spondyloarthropathies (SpA) such as ankylosing spondylitis (AS) where T cells may well also play an important role in the pathogenesis. This article focusses on the immunopathology of the SpA, ReA, and AS with special reference to T cells and cytokines.
Similar content being viewed by others
References and Recommended Reading
Sieper J, Braun J: Pathogenesis of spondylarthropathies. Persistent bacterial antigen, autoimmunity, or both? Arthritis Rheum 1995, 38:1547–1554.
Braun J, Laitko S, Treharne J, et al.: Chlamydia pneumoniae—a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994, 53:100–105.
Wilkinson NZ, Kingsley GH, Sieper J, et al.: The detection of Chlamydia trachomatis but not Chlamydia pneumoniae in the synovium of patients with a range of rheumatic diseases. Arthritis Rheum 1998, 41:845–854. Important paper linking the absence of bacterial DNA with an efficient immune response.
Bas S, Griffais R, Kvien TK, et al.: Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995, 38:1005–113.
Braun J, Tuszewski M, Eggens U, et al.: Nested PCR strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. I. Screening of synovial fluid samples of patients with spondyloarthropathies and other arthritides. J Rheumatol 1997, 24:1092–1100.
Fendler C, Braun J, Eggens U, et al.: Bacteria-specific lymphocyte proliferation in peripheral blood in reactive arthritis and related disease. Brit J Rheumatol. 1998, 37:520–524. This study shows that the best chances of detecting a specific lymphocyte proliferation are in the first 4 weeks after the onset of arthritis.
Sieper J, Braun J, Wu P, Kingsley G: T cells are responsible for the enhanced synovial cellular immune response to triggering antigen in reactive arthritis. Clin Exp Immunol 1993, 91:96–102.
Fendler C, Wu P, Eggens U, et al.: Longitudinal investigation of bacterium-specific synovial lymphocyte proliferation in reactive arthritis and Lyme arthritis. Brit J Rheumatol 1997, 37:784–788. Interesting report on repeated synovial lymphocyte proliferation to ReA-associated microbes suggesting that the antigen-specific response to Chlamydia, Shigella and Borrelia is quite consistent over time while the response to Yersinia mis less specific.
Braun J, Grolms M, Distler A, Sieper J: The specific antibacterial proliferation of reactive arthritis synovial T cells is not due to their higher proportion of CD45RO+ cells compared to peripheral blood. J Rheumatol 1994, 21:1702–1707.
Duchmann R, May E, Ackermann B, et al.: HLA-B27-restricted cytotoxic T lymphocyte responses to arthritogenic enterobacteria or self-antigens are dominated by closely related TCRBV gene segments. A study in patients with reactive arthritis. Scand J Immunol 1996, 43:101–108.
Allen RL, Gillespie JMA, Hall F, et al.: Multiple T cell expansion are found in the blood and synovial fluzid of patients with reactive arthritis. J Rheumatol 1997, 24:1750–1757.
Braun J, Grolms M, Sieper J: Three-colour flowcytometric examination of CD4/CD45 subsets reveals no differences in peripheral blood and synovial fluid between patients with reactive arthritis and rheumatoid arthritis. Clin Exp Rheumatol 1994, 12:17–22.
Probst P, Hermann E, Meyer zum Buschenfelde KH, Fleischer B:Identification of the Yersinia enterocolitica urease beta subunit as a target antigen for human synovial T lymphocytes in reactive arthritis. Infect Immun 1993, 61:4507–4509.
Mertz AK, Daser A, Skurnik M, et al.: The evolutionarily conserved ribosomal protein L23 and the cationic urease beta-subunit of Yersinia enterocolitica O:3 belong to the immunodominant antigens in Yersinia-triggered reactive arthritis: implications for autoimmunity. Mol Med 1994, 1:44–55.
Mertz AKH, Ugrinovic S, Lauster R, et al.: Characterization of the synovial T cell response to various recombinant Yersinia antigens in Yersinia-triggered reactive arthritis: the hsp60 drives a major immune response. Arthritis Rheum 1998, 41:315–326. The 60 kD heat shock protein of Yersinia seems to play an important role in the pathogenesis of Yersinia-triggered reactive arthritis.
Gaston JS, Deane KH, Jecock RM, Pearce JH: Identification of 2 Chlamydia trachomatis antigens recognized by synovial fluid T cells from patients with Chlamydia induced reactive arthritis. J Rheumatol 1996, 23:130–136.
Deane KH, Jecock RM, Pearce JH, Gaston JS: Identification and characterization of a DR4-restricted T cell epitope within chlamydia heat shock protein 60. Clin Exp Immunol 1997, 109:439–445.
Benjamin RJ, Parham P: Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990, 11:137–142.
Hermann E, Yu DT, Meyer zum BuschenfeldeKH, Fleischer B:HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet 1993, 342:646–650.
Ugrinovic S, Mertz A, Wu P, et al.: A single nonamer from the Yersinia 60kd heat shock protein is the target of HLA-B27 restricted CTL response in Yersinia-induced reactive arthritis. J Immunol 1997, 159:5715–5723.
Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383:787–793.
Schlaak J, Hermann E, Ringhoffer M, et al.: Predominance of Th1-type T cells in synovial fluid of patients with Yersiniainduced reactive arthritis. Eur J Immunol 1992, 22:2771–2776.
Simon AK, Seipelt E, Wu P, et al.: Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset. Clin Exp Immunol 1993, 94:122–126.
Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 1994, 91:8562–8566.
Yin Z, Braun J, Neure L, et al.: Crucial role of interleukin-10/ inter-leukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum 1997, 40:1788–1797.
Yin Z, Braun J, Neure L, et al.: T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum 1997, 40:69–79.
Tak PP, Smeets TJM, Dolhain RJEM, et al.: Analysis of the synovial infiltrate and expression of cytokines in rheumatoid arthritis compared with Yersinia-induced arthritis patients in relation to disease duration. Arthritis Rheum 1997, 40:S252.
Thurkow EW, van der Heijden IM, Breedveld FC, et al.:Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis. J Pathol 1997, 181:444–450.
Shigeru K, Schumacher HR, Yarboro CH, et al.: In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis. Proc Assoc Am Phys 1997, 109:286–302.
Murray KJ, Grom AA, Thompson SD, et al.: Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin-4 in restricted disease. J Rheumatol 1998, 25:1388–1398. This study suggests that the presence of IL-4 in the synovium is correlated with a better outcome of juvenile chronic arthritis.
Steiner G, Studnicka-Benke A, Witzmann G, et al.: Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. J Rheumatol 1995, 22:406–412.
Schlaak JF, Pfers I, Meyer Zum BuschenfeldeKH, Marker Hermann E: Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin Exp Rheumatol 1996, 14:155–162.
Yin Z, Neure L, Grolms M, et al.: Th1/Th2 cytokine pattern in the joint of rheumatoid arthritis and reactive arthritis patients: analysis at the single cell level. Arthritis Rheum 1997, 40:S37.
Picker LJ, Singh MK, Zdraveski Z, et al.: Direct demonstration of cytokine synthesis heterogeneity among human memory/ effector T cells by flow cytometry. Blood 1995, 86:1408–1412.
van Roon JA, van Eden W, van Roy JL, et al.: Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997, 100:459–463.
Yi Y, Yang X, Brunham RC: Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10. Infect Immun 1997, 65:1669–1674.
Holland MJ, Bailey RL, Conway DJ, et al.: T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996, 105:429–435.
Rodel J, Straube E, Lungershausen W, et al.: Secretion of cytokines by human synoviocytes during in vitro infection with Chlamydia trachomatis. J Rheumatol 1998, 25:2161–2168. Fibroblast-like synovial cells support chlamydial growth in vitro. Chlamydia stimulate synoviocytes to produce IL-6 and TGF-beta.
Williams DM, Grubbs BG, Darville T, et al.: A role for interleukin-6 in host defense against murine Chlamydia trachomatis infection. Infect Immun 1998, 66:4564–4567.
Perry LL, Feilzer K, Caldwell HD: Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium. Infect Immun 1998, 66:1265–1269.
Yang X, Gartner J, Zhu L, et al.: IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Immunol 1999, 162:1010–1017.
Lampe MF, Wilson CB, Bevan MJ, Starnbach MN: Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun 1998, 66:5457–5461. This paper shows that the IFNg production of cytotoxic CD8+ T cells is essential to fight chlamydial infections in an animal model.
Prakken AB, van Hoeij MJ, Kuis W, et al.: T-cell reactivity to human HSP60 in oligo-articular juvenile chronic arthritis is associated with a favorable prognosis and the generation of regulatory cytokines in the inflamed joint. Immunol Lett 1997, 57:139–142.
Granfors K, Merilahti-Palo R, Luukainen R, et al.: Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia entrocolitica 0:3 infection with or without reactive arthritis. Arthritis Rheum 1998, 41:855–862. Fascinating study showing that Yersinia can persist in peripheral blood cells for years and that yersinia heat shock protein is expressed in synovial cells.
Clerici M, Shearer GM: A TH1-TH2 switch is the critical step in the etiology of HIV infection. Immunol Today 1993, 14:107–111.
Bentvich Z, Kalinkovich A, Weisman Z: Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995, 16:187–191.
Njobvu PD, McGill PE, Jellis JE, Pobee JOM: Rheumatic disorders at a Zambian teaching hospital. Brit J Rheumatol 1996, 36:404–405.
Braun J, Yin Z, Krause A, et al.: Peripheral blood cells of reactive arthritis patients secrete more IL-10 and less TNF-alpha than patients with Lyme-or rheumatoid arthritis. Arthritis Rheum 1997, 40:S79.
Siegert S, Yin Z, Grolms M, et al.: Evidence for differences in cytokine secretion by peripheral blood cells of HLA B27-positive vs -negative healthy subjects. Clin Exp Rheumatol 1998, 16:215.
Claudepierre P, Rymer JC, Chevalier X: IL-10 plasma levels correlate with disease activity in spondyloarthropathy. J Rheumatol 1997, 24:1659–1661.
Gratacos J, Collado A, Filella X, et al.: Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994, 33:927–931.
Falkenbach A, Herold M: In ankylosing spondylitis serum interleukin-6 correlates with the degree of mobility restriction, but not with short term changes in the variables of mobility. Rheumatol Int 1998, 18:103–106.
Leino R, Vuento R, Koskimies S, et al.: Depressed lymphocyte transformation by yersinia and E.coli in yersinia arthritis. Ann Rheum Dis 1983, 42:176–181.
Vuento R, Leino R, Viander M, Toivanen A: In vitro lymphoproliferative response to Yersinia: depressed response in arthritic patients years after Yersinia infection. Clin Exp Rheumatol 1983, 1:219–224.
Hermann E, Grabe H, Mayet W-J, et al.: Lower frequency of Yersinia-reactive peripheral blood T cells in acute Yersinia-induced arthritis—indication of a defective first line of defense? Clin Rheumatol 1992, 11:158.
Groux H, O’Garra A, Bigler M, et al.: CD4+ T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997, 389:737–742.
Brewerton D, Hart F, Nicholls A, et al.: Ankylosing spondylitis and HLA27. Lancet 1973, 1:904–907.
Nikbin B, Brewerton DA, James DCO, et al.: Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals, all with HLA B27. Ann Rheum Dis 1976, 35:37–39.
Brenner MB, Kobayashi S, Wiesenhutter CW, et al.: In vitro T lymphocyte proliferative response to Yersinia enterocolitica in Reiter’s syndrome. Lack of response in other HLA B27 positive individuals. Arthritis Rheum 1984, 27:250–257.
Inman RD, Chiu B, Johnston ME, et al.: HLA class I-related impairment in IL-2 production and lymphocyte response to microbial antigens in reactive arthritis. J Immunol 1989, 142:4256–4260.
Toivanen P, Koskimies S, Granfors K, Eerola E: Bacterial antibodies in HLA-B27+ healthy individuals. Arthritis Rheum 1993, 36:1633–1635.
Hermann E, Sucke B, Droste U, Meyer zum Büschenfelde HK:Klebsiella pneumoniae-reactive T cells in blood and synovial fluid of patients with ankylosing spondylitis. Comparison with HLA B27+ healthy control subjects in a limiting dilution study and determination of the specificity of synovial fluid T cell clones. Arthritis Rheum 1995, 38:1277–1282.
Seitz M, Lemmel EM, Homfeld J, Kirchner H: Enhanced interferon-gamma production by lymphocytes induced by a mitogen from mycoplasma arthritidis in patients with ankylosing spondylitis. Rheumatol Int 1989, 9:85–90.
Brand JM, Neustock P, Kruse A, et al.: Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from mykoplasma arthritidis and other mitogens. Rheumatol Int 1996, 16:207–211.
ten Hagen TL, van Vianan W, Savelkoul HF, et al.: Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gammainterferon. Infect Immun 1998, 66:1962–1967.
Tiwana H, Walmsley RS, Wilson C, et al.: Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br J Rheumatol 1998, 37:525–531. Interesting paper linking the presence of anti-Klebsiella antibodies to gut permeability.
Maki-Ikola O, Nissila M, Lehtinen K, Granfors K: IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis. Br J Rheumatol 1998, 37:1299–1302. A broad range of Klebsiella serotypes may be involved in the pathogenesis of AS.
Cancino-Diaz ME, Perez-Salazar JE, Dominguez-Lopez L, et al.:Antibody response to Klebsiella pneumoniae 60 kDa protein in familial and sporadic ankylosing spondylitis: role of HLAB27 and characterization as a GroEL-like protein. J Rheumatol 1998, 25:1756–1764. In this study, HLA-B27+ individuals, independent of their disease status, show a significant higher response to the 60 kDa protein of K. pneumoniae than HLA-B27 subjects.
Ahmadi K, Wilson C, Tiwana H, et al.: Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis. Br J Rheumatol 1998, 37:1330–1333. AS patients had significantly elevated levels of IgG and IgA antibodies against K. pneumoniae LPS and IgA antibodies against E. coli LPS compared to healthy controls.
Walmsley RS, Anthony A, Sim R, et al.: Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol 1998, 51:657–661. No bacterial DNA was found in gut biopsies of patients with Crohn’s disease despite elevated antibodies to Klebsiella.
Tanchot C, Guillaume S, Delon J, et al.: Modifications of CD8+ T cell function during in vivo memory and tolerance induction. Immunity 1998, 8:581–590.
Brown MA, Pile KD, Kennedy G, et al.: A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998, 41:588–595. Important study showing that only one third of the genetic risk to get AS is due to HLA B27.
van der Linden MW, Huizinga TW, Stoeken DJ, et al.:Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods 1998, 218:63–71.
Louis E, Franchimont D, Piron A, et al.: Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998, 113:401–406.
Westendorp RG, Langermans JA, Huizinga TW, et al.: Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997, 349:170–173.
Cabrera M, Shaw MA, Sharples C, et al.: Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1993, 182:1259–1264.
McGuire W, Hill AVS, Allsopp CEM, et al.: Variation in the TNF-a promoter region associated with cerebral malaria. Nature 1994, 371:508–511.
Bouma G, Crusius JB, Oudkerk Pool M, et al.: Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996, 43:456–463.
Brown MA, Kennedy LG, Darke C, et al.: The effect of HLA DR genes on susceptibility and severity of ankylosing spondylitis. Arthritis Rheum 1998, 41:460–466.
Conway DJ, Holland MJ, Bailey RL, et al.: Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNFalpha levels in tear fluid. Infect Immun 1997, 65:1003–1006.
Wilson GA, de Vries N, Pociot F, et al.: An allelic polymorphism within the human tumour necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR 3 alleles. J Exp Med 1993, 177:557–560.
Wilson AG, Symons JA, McDowell TL, et al.: Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci 1997, 94:3195–3199.
Kaijzel EL, Brinkman BM, van Krugten MV, et al.: Polymorphism within the tumor necrosis factor alpha (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol 1999, 60:140–144.
Verjans GM, Brinkman BM, van Dornik CE, et al.: Polymorphism of tumour necrosis factor-alpha at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994, 97:45–47.
Fraile A, Nieto A, Beraun Y, et al.: Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens 1998, 51:386–390.
Hohler T, Schaper T, Schneider PM, et al.: Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998, 41:1489–1492.
Tuokko J, Koskinen S, Westman P, et al.: Tumour necrosis factor microsatellites in reactive arthritis. Br J Rheumatol 1998, 37:1203–1206.
Yang X, HayGlass T, Brunham RC: Genetically determined differences in IL-10 and IFNg-responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996, 156:4338–4344.
Llorente L, Richaud Patin Y, Couderc J, et al.: Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 1997, 40:1429–1435.
Eskdale J, Wordsworth BP, Bowman S, et al.: Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens 1997, 49:635–639.
Mok CC, Lanchbury JS, Chan DW, Lau CS: Interleukin10 promoter polymorphisms in southern chines patients with systemic lupus erythematosus. Arthritis Rheum 1998, 41:1090–1095.
Keijsers V, Verweij CL, Hazes M, et al.: Innate differences in IL-10 production are present at the level of transcription and associated with haplotypes: association of IL-10 haplotypes and rheumatoid arthritis. Clin Exp Rheumatol 1998, 16:200.
Braun J, Sieper J: The sacroiliac joint in the spondylarthropathies. Curr Opin Rheumatol 1996, 7:275–283.
Leirisalo-Repo M, Helenius P, Hannu T, et al.: Longterm prognosis of reactive salmonella arthritis. Ann Rheum Dis 1997, 56:516–520.
Brandt J, Bollow M, Häberle HJ, et al.: Not all patients with sacroiliitis have spondyloarthropathy—a clinical study of inflammatory back pain and arthritis of the lower limbs. Rheumatology 1999, in press.
Braun J, Bollow M, Remlinger G, et al.: Prevalence of spondylarthropathies in HLA B27-positive and -negative blood donors. Arthritis Rheum 1998, 41:58–67. This study suggests that the prevalence of SpA is higher than previously thought. HLA B27-positivity increases the probability of sacroiliitis (proven by MRI) and SpA in individuals with inflammatory back pain.
Bollow M, Braun J, Kannenberg J, et al.: Normal morphology of sacroiliac joints in children: magnetic resonance studies related to age and sex. Skeletal Radiol 1997, 26:697–704.
Bollow M, Biedermann T, Kannenberg J, et al.: Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA B27-positive and -negative children with juvenile arthritides. J Rheumatol 1998, 25:556–564. Elegant study showing that MRI is useful to detect sacroiliitis in children.
Braun J, Tuszewski M, Ehlers S, et al.: Nested PCR strategy simultaneously targeting DNA sequences of multiple bacterial species in inflammatory joint diseases. II. Examination of sacroiliac and knee joint biopsies of patients with spondyloarthropathies and other arthritides. J Rheumtol 1997, 24:1101–1105.
Braun J, Bollow M, Sieper J: Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am 1998, 24:697–735. Comprehensive review on SpA radiology and pathology.
Jobanputra P, Choy EH, Kingsley GH, et al.: Cellular immunity to cartilage proteoglycans: relevance to the pathogenesis of ankylosing spondylitis. Ann Rheum Dis 1992, 51:959–962.
Leroux JY, Guerassimov A, Cartman A, et al.: Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo. J Clin Invest 1996, 97:621–632.
Guerassimov A, Zhang Y, Banerjee S, et al.: Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 1998, 25:1480–1484. This study shows an enhanced proliferative response to link protein in AS patients.
Poole AR: The histopathology of ankylosing spondylitis: are there unifying hypotheses? Am J Med Sci 1998, 316:228–233. Excellent review on histopathology and possible autoantigens in AS.
Francois RJ: Le rachis dans la spondylarthrite ankylosante. Brussels, Belgium: Editions Arscia, 1976.
Shichikawa K, Tsujimoto M, Nishioka J, et al.: Histopathology of early sacroiliitis and enthesitis in ankylosing spondylitis. In Advances in Inflammation Research, Vol 9: The Spondyloarthropathies. Edited by Ziff M, Cohen SB. New York, Raven Press; 1985.
Braun J, Bollow M, Neure L, et al.: Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995, 38:499–505.
Braun J, Bollow M, Eggens U, et al.: Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994, 37:1039–1045.
McGonagle D, Gibbon W, Emery P: Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352:1137–1140. Interesting hypothesis based on newer and older data on the involvement of entheseal structures in SpA.
McGonagle D, Gibbon W, O’Connor P, et al.: Characteristic MRI entheseal changes of knee synovitis in spondyloarthropathy. Arthritis Rheum 1998, 41:694–700. Very interesting paper using MRI to show that knee arthritis in SpA and RA is anatomically different due to an enhanced frequency of enthesitis in SpA.
Ball J: Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 1971, 30:213–223.
Dougados M, van der Linden S, Juhlin R, et al.: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34:1218–1227.
Lehtinen A, Taavitsainen M, Leirisalo Repo M: Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy. Clin Exp Rheumatol 1994, 12:143–148.
Olivieri I, Barozzi L, Padula A: Enthesiopathy: clinical manifestations, imaging and treatment. Baillieres Clin Rheumatol 1998, 12:665–681. Comprehensive review on diagnosis and treatment of enthesitis in SpA.
Francois RF, Gardner DL, Bywaters EGL: The sacroiliac joint in ankylosing spondylitis. Rheumatology in Europe 1995, 24:87.
Braun J, Neure L, Francois R, et al.: Immunohistologic examinations of sacroiliac inflammation in ankylosing spondylitis. Arthritis Rheum 1998, 41:S112.
Olivieri I, Barozzi L, Favaro L, et al.: Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum 1996, 39:1524–1528.
Zink A, Braun J, Listing A, Wollenhaupt J, and the German Colloborative Research Centers: The burden of illness in ankylosing spondylitis is comparable. Arthritis Rheum 1997, 40:S227.
Eulderink F: Pathology of ankylosing spondylitis. Spine, State of the Art Reviews 1990, 4:507–528.
De Vlam K, Mielants H, Veys EM: Involvement of the zygapophyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyte. Arthritis Rheum 1998, 41:S113.
Bollow M, Brandt J, Häberle HJ, et al.: Use of magnetic resonance imaging to detect spinal inflammation in spondyloarthropathy. Arthritis Rheum 1998, 41:S358.
Eulderink F, Ivanyi P, Weinreich S: Histopathology of murine ankylosing enthesopathy. Pathol Res Pract 1998, 194:797–803.
Weinreich SS, Hoebe-Hewryk B, van der Horst AR, et al.:The role of MHC class I heterodimer expression in mouse ankylosing enthesopathy. Immunogenetics 1997, 46:35–40.
Braun J, Bollow M, Seyrekbasan SF, et al.: Computed tomography corticosteroid injection of the sacroiliac joint in patients with spondylarthropathy with sacroiliitis: clinical outcome and followup by dynamic magnetic resonance imaging. J Rheumatol 1996,
Braun J, Bollow M, Wu P, et al.: Further examination of sacroiliac biopsies from spondylarthropathy patients—investigation of the cytokine pattern and of bacterial DNA. Arthritis Rheum 1995, 38:S315.
Bollow M, Fischer T, Reißhauer H, et al.: T cells and macrophages predominate in early and active sacroiliitis as detected by magnetic resonance imaging in spondyloarthropathies. Arthritis Rheum 1998, 41:S111.
Kidd BL, Moore K, Walters MT, et al.: Immunohistological features of synovitis in ankylosing spondylitis: a comparison with rheumatoid arthritis. Ann Rheum Dis 1989, 48:92–98.
Cunnane G, Bresnihan B, Fitzgerald O: Immunohistologic analysis of peripheral joint disease in ankylosing spondylitis. Arthritis Rheum 1998, 41:180–182. Important study on immunohistology of peripheral joints in AS showing that T cells and macrophages are involved.
Beacock-Sharp H, Young JL, Gaston JSH: Analysis of T cell subsets present in the peripheral blood and synovial fluid of reactive arthritis patients. Ann Rheum Dis 1998, 57:100–106. This study shows that the synovial CD4+ and CD8+ T cells are activated in ReA.
Kirveskari J, Jalkanen S, Maki-Ikola O, Granfors K: Increased synovial endothelium binding and transendothelial migration of mononuclear cells during Salmonella infection. Arthritis Rheum 1998, 41(6):1054–1063. Interesting study showing that peripheral blood mononuclear cells show increased binding to synovial endothelial cells during Salmonella infections.
Nikkari S, Rantakokko K, Ekman P, et al.: Salmonella-triggered reactive arthritis: use of polymerase chain reaction, immunocytochemical staining, and gas chromatography-mass spectrometry in the detection of bacterial components from synovial fluid. Arthritis Rheum 1999, 42(1):84–89. Important study suggesting that only dead Salmonella are transported via the blood to the joint.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Braun, J., Sieper, J. Cytokines and the immunopathology of the spondyloarthropathies. Curr Rheumatol Rep 1, 67–77 (1999). https://doi.org/10.1007/s11926-999-0028-y
Issue Date:
DOI: https://doi.org/10.1007/s11926-999-0028-y